Xenon Pharmaceuticals Inc... (XENE)
NASDAQ: XENE
· Real-Time Price · USD
29.53
-0.21 (-0.71%)
At close: May 15, 2025, 3:59 PM
29.57
0.14%
After-hours: May 15, 2025, 04:43 PM EDT
Xenon Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| License and Service Revenue | 9.43M |
| License and Service Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 18M | 16.71M | 19.4M | 14.19M | 11.77M | 12.8M | 11.58M | 9.54M | 8.5M | 8.83M | 8.71M | 6.78M | 6.69M | 4.83M | 6.34M | 4.11M | 3.11M | 3.21M | 3.31M | 3.32M | 3.17M | 2.7M | 2.31M | 2.62M | 2.03M | 1.94M | 2.18M | 2.24M | 1.67M | 1.74M | 1.8M | 2.1M | 1.44M | 1.78M | 1.68M | 1.9M | 1.57M | 1.32M | 178K | 1.79M |
| Selling, General, and Administrative Revenue Growth | +7.78% | -13.90% | +36.71% | +20.60% | -8.09% | +10.53% | +21.49% | +12.16% | -3.72% | +1.42% | +28.49% | +1.30% | +38.44% | -23.79% | +54.27% | +32.29% | -3.18% | -3.08% | -0.30% | +4.57% | +17.59% | +17.04% | -11.98% | +29.24% | +4.64% | -11.02% | -2.68% | +34.01% | -4.24% | -3.06% | -14.33% | +45.63% | -18.94% | +6.15% | -11.56% | +20.93% | +18.62% | +642.13% | -90.05% | n/a |
| Research and Development Revenue | 58.84M | 56.97M | 49.7M | 44.25M | 41.08M | 42.88M | 44.04M | 39.52M | 34.83M | 29.43M | 22.15M | 19.36M | 21.89M | 18.89M | 18.38M | 16.31M | 14.97M | 13.04M | 10.72M | 11.79M | 11.75M | 9.75M | 8.21M | 9.14M | 6.41M | 6.24M | 5.41M | 5.58M | 6.4M | 7.16M | 6.11M | 5.9M | 4.4M | 5.96M | 5.1M | 4.36M | 4.26M | 3.79M | 3.67M | 3.43M |
| Research and Development Revenue Growth | +3.28% | +14.62% | +12.32% | +7.73% | -4.21% | -2.63% | +11.45% | +13.45% | +18.34% | +32.90% | +14.39% | -11.55% | +15.86% | +2.80% | +12.69% | +8.96% | +14.73% | +21.69% | -9.08% | +0.33% | +20.52% | +18.84% | -10.20% | +42.63% | +2.66% | +15.38% | -3.08% | -12.77% | -10.71% | +17.27% | +3.49% | +34.28% | -26.30% | +16.89% | +16.93% | +2.37% | +12.39% | +3.38% | +7.06% | n/a |